Craig Gibbs is the founder of Asher Bio. Asher Bio has raised $215M in total funding. Latest round: Series C. Based in South San Francisco, CA.
Craig Gibbs is the Co-founder and CEO of Asher Biotherapeutics (Asher Bio), a biotechnology company. He led the company out of stealth in March 2021 with $55 million in Series A funding and has subsequently secured over $160 million in Series A and B financing before closing a $55 million Series C in April 2024. Gibbs has positioned Asher Bio to advance its lead program into Phase 1b clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library